CompletedPhase 1NCT01173016
Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
Studying Hurler syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Paul Orchard, MDMasonic Cancer Center, University of Minnesota
- Intervention
- Laronidase(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 14 years · All sexes
- Timeline
- 2012 – 2016
Study locations (1)
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01173016 on ClinicalTrials.govOther trials for Hurler syndrome
Additional recruiting or active studies for the same condition.